Cargando…
Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics
Ex vivo human tumor models have emerged as promising, yet complex tools to study cancer immunotherapy response dynamics. Here, we present a strategy that integrates empirical data from an ex vivo human system with computational models to interpret the response dynamics of a clinically prescribed PD-...
Autores principales: | Smalley, Munisha, Przedborski, Michelle, Thiyagarajan, Saravanan, Pellowe, Moriah, Verma, Amit, Brijwani, Nilesh, Datta, Debika, Jain, Misti, Shanthappa, Basavaraja U., Kapoor, Vidushi, Gopinath, Kodaganur S., Doval, D.C., Sabitha, K.S., Taroncher-Oldenburg, Gaspar, Majumder, Biswanath, Majumder, Pradip, Kohandel, Mohammad, Goldman, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303667/ https://www.ncbi.nlm.nih.gov/pubmed/32554190 http://dx.doi.org/10.1016/j.isci.2020.101229 |
Ejemplares similares
-
Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade
por: Przedborski, Michelle, et al.
Publicado: (2021) -
Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2
por: Brijwani, Nilesh, et al.
Publicado: (2017) -
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
por: Majumder, Biswanath, et al.
Publicado: (2015) -
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
por: Goldman, Aaron, et al.
Publicado: (2015) -
Reinforcement learning derived chemotherapeutic schedules for robust patient-specific therapy
por: Eastman, Brydon, et al.
Publicado: (2021)